|
EIF3H expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.158600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.758600E-01 |
| Normal-vs-Stage2 |
9.662200E-01 |
| Normal-vs-Stage3 |
3.635600E-01 |
| Normal-vs-Stage4 |
2.080300E-02 |
| Stage1-vs-Stage2 |
4.931000E-01 |
| Stage1-vs-Stage3 |
9.953900E-02 |
| Stage1-vs-Stage4 |
1.038530E-04 |
| Stage2-vs-Stage3 |
4.707600E-01 |
| Stage2-vs-Stage4 |
5.557600E-03 |
| Stage3-vs-Stage4 |
9.916000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.322800E-01 |
| Normal-vs-AfricanAmerican |
3.271600E-01 |
| Normal-vs-Asian |
7.912600E-01 |
| Caucasian-vs-AfricanAmerican |
3.729800E-01 |
| Caucasian-vs-Asian |
6.551400E-01 |
| AfricanAmerican-vs-Asian |
6.469400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.142380E-01 |
| Normal-vs-Female |
6.063900E-02 |
| Male-vs-Female |
7.200800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.812800E-01 |
| Normal-vs-Extreme_Weight |
3.130600E-01 |
| Normal-vs-Obese |
3.091200E-01 |
| Normal-vs-Extreme_Obese |
1.111160E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.705600E-01 |
| Normal_Weight-vs-Obese |
5.021400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.218370E-01 |
| Extreme_Weight-vs-Obese |
7.656200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.094600E-01 |
| Obese-vs-Extreme_Obese |
6.715600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.898500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.743600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.151800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.757400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.771800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.190500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.253900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.750600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.352800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.592800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.310000E-02 |
| Normal-VS-Type2 PRCC |
3.404200E-01 |
| Normal-VS-KIRP CIMP |
9.295400E-03 |
| Normal-VS-Unclassified PRCC |
3.456600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.655700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.87930000023529E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
5.227400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.059900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.137170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.98180000000293E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.679000E-01 |
| Normal-vs-N1 |
7.443900E-03 |
| Normal-vs-N2 |
1.125580E-01 |
| N0-vs-N1 |
6.603500E-04 |
| N0-vs-N2 |
9.889600E-02 |
| N1-vs-N2 |
1.172610E-01 |
|
|
